Journal article
Epilepsy, atherosclerosis, myocardial infarction, and carbamazepine
Journal of child neurology, v 18(2)
Feb 2003
PMID: 12693787
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Epileptic patients receiving medications such as phenytoin or phenobarbital have been noted to have an exceedingly low incidence of myocardial infarction, but children treated with carbamazepine have shown alteration of their serum lipid profile that could predispose them to atherosclerosis. This report seems to corroborate this point and describes the findings in an 11-year-old boy who died following a major seizure, rhabdomyolysis, and renal failure. The autopsy demonstrated that he had marked coronary atherosclerosis and myocardial infarction. The child had been treated with carbamazepine for more than 10 years.
Metrics
Details
- Title
- Epilepsy, atherosclerosis, myocardial infarction, and carbamazepine
- Creators
- Jean-Pierre de Chadarévian - Drexel UniversityAgustin Legido - Drexel UniversityDaniel K Miles - Drexel UniversityChristos D Katsetos - St. Christopher's Hospital for Children
- Publication Details
- Journal of child neurology, v 18(2)
- Publisher
- Sage
- Resource Type
- Journal article
- Language
- English
- Web of Science ID
- WOS:000181922500015
- Scopus ID
- 2-s2.0-17944398648
- Other Identifier
- 991019353721404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Clinical Neurology
- Pediatrics